As Clostridium difficile creates a significant economic and morbidity burden for hospitals, researchers with Cleveland Clinic and the University of Texas School of Public Health in Houston sought to ...

Researchers examined 72 patients who had at least three bouts of recurrent C. diff in a clinical trial. They treated the patients with fresh, frozen or freeze-dried fecal microbiota transplant ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...

In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for Sick Children (SickKids) have uncovered how the body's bile acids bind to ...

Bethesda, MD (Feb. 21, 2024) — In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological ...

Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

Vowst (fecal microbiota spores, live-brpk) is a brand-name oral capsule that’s prescribed to help prevent Clostridioides difficile (C. diff) infection returning after antibiotic treatment in certain ...

After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, ...

Researchers at Tufts University School of Medicine are studying C. diff at multiple levels, from how individual bacterial ...